Androgen-induced upregulation of CFTR in pancreatic β-cell contributes to hyperinsulinemia in PCOS model
- PMID: 37922092
- DOI: 10.1007/s12020-023-03516-2
Androgen-induced upregulation of CFTR in pancreatic β-cell contributes to hyperinsulinemia in PCOS model
Erratum in
-
Correction to: Androgen-induced upregulation of CFTR in pancreatic β-cell contributes to hyperinsulinemia in PCOS model.Endocrine. 2024 Nov;86(2):860-861. doi: 10.1007/s12020-024-03821-4. Endocrine. 2024. PMID: 38782863 No abstract available.
Abstract
Purpose: Polycystic ovarian syndrome (PCOS) is an endocrine-metabolic condition affecting 5-10% of reproductive-aged women and characterized by hyperandrogenism, insulin resistance (IR), and hyperinsulinemia. CFTR is known to be regulated by steroid hormones, and our previous study has demonstrated an essential role of CFTR in β-cell function. This study aims to investigate the contribution of androgen and CFTR to hypersecretion of insulin in PCOS and the underlying mechanism.
Methods: We established a rat PCOS model by subcutaneously implanting silicon tubing containing Dihydrotestosterone (DHT). Glucose tolerance test with insulin levels was performed at 9 weeks after implantation. A rat β-cell line RINm5F, a mouse β-cell line β-TC-6, and mouse islets were treated with DHT, and with or without the androgen antagonist flutamide for CFTR and insulin secretion-related functional assays or mRNA/protein expression measurement. The effect of CFTR inhibitors on DHT-promoted membrane depolarization, glucose-stimulated intracellular Ca2+ oscillation and insulin secretion were examined by membrane potential imaging, calcium imaging and ELISA, respectively.
Results: The DHT-induced PCOS model showed increased body weight, impaired glucose tolerance, and higher blood glucose and insulin levels after glucose stimulation. CFTR was upregulated in islets of PCOS model and DHT-treated cells, which was reversed by flutamide. The androgen receptor (AR) could bind to the CFTR promoter region, which was enhanced by DHT. Furthermore, DHT-induced membrane depolarization, enhanced glucose-stimulated Ca2+ oscillations and insulin secretion, which could be abolished by CFTR inhibitors.
Conclusions: Excessive androgen enhances glucose-stimulating insulin secretion through upregulation of CFTR, which may contribute to hyperinsulinemia in PCOS.
Keywords: Androgen; CFTR; Hyperinsulinemia; Insulin; Polycystic ovary syndrome; β cell.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.J Mol Med (Berl). 2021 Oct;99(10):1427-1446. doi: 10.1007/s00109-021-02104-z. Epub 2021 Jun 28. J Mol Med (Berl). 2021. PMID: 34180022 Free PMC article.
-
Elevated androgen levels induce hyperinsulinemia through increase in Ins1 transcription in pancreatic beta cells in female rats.Biol Reprod. 2018 Apr 1;98(4):520-531. doi: 10.1093/biolre/ioy017. Biol Reprod. 2018. PMID: 29365042 Free PMC article.
-
Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).Endocrinology. 2015 Nov;156(11):4071-80. doi: 10.1210/en.2015-1159. Epub 2015 Aug 31. Endocrinology. 2015. PMID: 26322372
-
Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS.J Endocrinol. 2025 Mar 12;265(2):e240269. doi: 10.1530/JOE-24-0269. Print 2025 May 1. J Endocrinol. 2025. PMID: 40013621 Free PMC article. Review.
-
Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome.Baillieres Clin Endocrinol Metab. 1996 Apr;10(2):221-47. doi: 10.1016/s0950-351x(96)80085-1. Baillieres Clin Endocrinol Metab. 1996. PMID: 8773746 Review.
Cited by
-
Papillary thyroid carcinoma: ≤ 10 mm does not always mean pN0. A multicentric real-world study.Updates Surg. 2024 Jun;76(3):1055-1061. doi: 10.1007/s13304-024-01779-6. Epub 2024 Mar 6. Updates Surg. 2024. PMID: 38446376 Free PMC article.
References
-
- M.O. Goodarzi, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol. 7(4), 219–231 (2011). - PubMed
-
- R.A. Wild, Long-term health consequences of PCOS. Hum. Reprod. Update 8(3), 231–241 (2002). - PubMed
-
- C.M. DeUgarte, A.A. Bartolucci, R. Azziz, Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil. Steril. 83(5), 1454–1460 (2005). - PubMed
-
- S. Hahn et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm. Metab. Res. 37(7), 438–444 (2005). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous